SAN DIEGO, April 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financial
The live call may be accessed by phone by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant code 44748374. The webcast can be accessed live on the "Investors" section of the Orexigen web site at www.orexigen.com, and will be archived for 14 days following the call.
Jason KeyesChief Financial OfficerOrexigen Therapeutics, Inc. [email protected]
Media Contact: Erika HackmannY&[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-and-discuss-first-quarter-2017-financial-results-on-may-9-2017-300445666.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All